Multi-Omics Integration

Core Idea

Multi-omics integration combines data from multiple molecular layers — genomics, transcriptomics, epigenomics, proteomics, metabolomics — to build comprehensive models of biological systems. No single omics layer captures the full picture: DNA variants explain predisposition, chromatin state explains regulatory potential, transcripts show regulatory activity, proteins show functional capacity, and metabolites show biochemical output. Integration methods range from simple overlap analysis to sophisticated statistical frameworks (MOFA, DIABLO, network-based methods) that identify shared and layer-specific sources of variation. Single-cell multiome technologies now measure multiple modalities (RNA + ATAC, RNA + protein) in the same cell, enabling within-cell integration.

How It's Best Learned

Take matched RNA-seq and ATAC-seq datasets from the same samples and use MOFA2 to identify shared and modality-specific factors of variation. Examine whether the top shared factor corresponds to the biological condition of interest (e.g., disease vs. healthy). Then explore single-cell multiome data (10x Multiome) where RNA and ATAC are measured in the same cells, and link enhancer accessibility to gene expression at single-cell resolution.

Common Misconceptions

• Multi-omics integration is not simply overlapping significant results from each layer — sophisticated methods are needed to account for different scales, distributions, noise levels, and dimensionalities across data types.
• More omics layers do not automatically produce better results — poorly designed experiments, batch effects, or mismatched samples can make integration counterproductive.

Explainer

Each omics technology provides a partial view of cellular biology: genomics shows the static blueprint, epigenomics shows the regulatory switches, transcriptomics shows which genes are active, proteomics shows the functional machinery, and metabolomics shows the biochemical output. Multi-omics integration aims to combine these partial views into a comprehensive picture — connecting genetic variation to molecular mechanisms to phenotypic outcomes.

The simplest integration approach is sequential analysis: perform GWAS to find disease-associated variants, check whether they fall in regulatory elements (using epigenomic maps), test whether they affect gene expression (using eQTL data), and trace the downstream effects on protein and metabolite levels. This hypothesis-driven approach is powerful when the biological question is specific (what does this variant do?) but cannot discover unexpected cross-layer relationships. Concatenation-based methods stack all omics features into a single matrix and apply standard multivariate analysis (PCA, clustering, classification), but this ignores the fundamentally different statistical properties of each data type.

Factor-based methods like MOFA (Multi-Omics Factor Analysis) and DIABLO provide a more principled framework. They decompose the variation across all omics layers into a small number of latent factors, identifying which factors are shared across layers (reflecting coordinated biological processes) and which are specific to individual layers (reflecting modality-specific technical or biological variation). A shared factor that separates disease from healthy samples across transcriptomics, proteomics, and metabolomics simultaneously is strong evidence for a coordinated biological program. The factor loadings identify which specific genes, proteins, and metabolites drive the pattern.

Single-cell multiome technologies represent the cutting edge. 10x Genomics Multiome simultaneously measures RNA expression and chromatin accessibility (ATAC) in the same cell. CITE-seq measures RNA and surface protein levels in the same cell. These paired measurements within individual cells eliminate the need for computational cross-modality matching and enable direct quantification of regulatory relationships: how does the accessibility of an enhancer in cell A relate to the expression of its target gene in that same cell? Methods like ArchR and Signac analyze multiome data by linking peaks to genes, identifying cell-type-specific regulatory elements, and building regulatory networks grounded in matched single-cell measurements. As these technologies mature — adding more modalities, more cells, and spatial resolution — multi-omics integration will increasingly move from population-level statistical associations to mechanistic single-cell models of gene regulation.